Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BankTheTrade Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::864584576.png) Palmer [@BankTheTrade](/creator/twitter/BankTheTrade) on x 8951 followers
Created: 2025-07-11 11:04:57 UTC

$CAPR XXXXX down XXXX received a Complete Response Letter (CRL) from the U.S. Food and Drug        Administration (FDA) regarding its Biologics License Application (BLA)        for Deramiocel, the Company's lead cell therapy candidate for the        treatment of cardiomyopathy associated with Duchenne muscular dystrophy        (DMD).


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1943627566885036155/c:line.svg)

**Related Topics**
[bla](/topic/bla)
[$capr](/topic/$capr)

[Post Link](https://x.com/BankTheTrade/status/1943627566885036155)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BankTheTrade Avatar Palmer @BankTheTrade on x 8951 followers Created: 2025-07-11 11:04:57 UTC

$CAPR XXXXX down XXXX received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) for Deramiocel, the Company's lead cell therapy candidate for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy (DMD).

XXX engagements

Engagements Line Chart

Related Topics bla $capr

Post Link

post/tweet::1943627566885036155
/post/tweet::1943627566885036155